The interventional neurology devices help in the diagnosis, prevention, and treatment of a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. These devices are minimally invasive image-based technologies. The procedures involving these devices are used in the diagnosis and treatment of diseases of the head, neck, and spine. According to a worldwide WHO report, the prevalence of Alzheimer's and other forms of dementia was nearly 3 per 1000 in 2018. Moreover, the geriatric population is rising globally which is more prone to mental disorders.
The "Global Interventional Neurology Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Interventional Neurology market with detailed market segmentation by products, applications, and geography. The report provides key statistics on the market status of the leading Interventional Neurology market players and offers key trends and opportunities in the market.
- Based on products, the global Interventional Neurology market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, neurothrombectomy devices.
- Based on application, the market is categorised into artery stenosis, ischemic strokes, brain aneurysm, vein stenosis, others.
- Growing target patient population.
- Rise in demand for minimally invasive neurosurgical procedures.
- Favorable medical reimbursements for neurological procedures.
- Increase in research in the field of neurovascular therapies
- High procedural cost of neurovascular surgeries and related products.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Interventional Neurology market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Interventional Neurology market in these regions.
IMPACT OF COVID-19 ON INTERVENTIONAL NEUROLOGY MARKET
As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of neurological procedures across all healthcare practice settings. Due to lockdown imposed by the governments across the world many neurological procedures were delayed, and supply chain restriction has limited the availability of resources needed to deliver imaging services. Moreover, the COVID-19 pandemic has disrupted the spectrum of clinical research, including delaying diagnoses and therapeutics and in few cases halting clinical trials.
The report covers key developments in the Interventional Neurology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Interventional Neurology market are anticipated to lucrative growth opportunities in the future with the rising demand for Interventional Neurology in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Interventional Neurology market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Johnson and Johnson
- Boston Scientific Corporation
- Stryker Corporation
- Medtronic PLC
- Terumo Corporation
- Penumbra, Inc.
- Microport Scientific Corporation
- Merit Medical Systems, Inc.
- W.L. Gore and Associates, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.